+44 3455007136  |  contact@probejournals.com
Follow us:

Journal of Infectious Diseases and Therapy

Home > Journals > Journal of Infectious Diseases and Therapy
Journal of Infectious Diseases and Therapy
Journal Cite Score: 2.89
Journal Impact Factor: 2.32
Overall acceptance and publication time: 07-25 days
Average article processing time: 10-20 days
Journal H-Index: 6
Please submit article at: publish@probejournals.com

Our Editors

Dr. Sukalyan Kumar Kundu

Dr. Sukalyan Kumar Kundu

Editor
Department of Pharmacy, Jahangirnagar University, Dhaka, Bangladesh
Dr. Yi Huang

Dr. Yi Huang

Sr. Statistical Data Analyst / Editor
Radiation Oncology, Washington University, Missouri, United States
Dr. Chaochao Qin

Dr. Chaochao Qin

Editor
Oncology Internal Medicine Treatment Unit, Guangyuan Traditional Chinese Medicine Hospital Affiliated to Chengdu University of Traditional Chinese Medicine, Guangyuan, China

Aim and scope

Journal of Infectious Diseases and Therapy is an international, peer-reviewed, open-access journal dedicated to publishing high-quality research on the prevention, diagnosis, treatment, and control of infectious diseases affecting human and animal populations. The journal provides a multidisciplinary platform for researchers, clinicians, microbiologists, epidemiologists, public health professionals, and healthcare practitioners to disseminate original scientific findings that enhance the understanding of infectious diseases and improve global health outcomes.

The journal welcomes Original Research Articles, Review Articles, Systematic Reviews, Meta-Analyses, Short Communications, Case Reports (where appropriate), Clinical Studies, Technical Notes, Perspectives, and Editorials. Through rigorous peer review and adherence to the highest standards of scientific integrity and publication ethics, the journal promotes evidence-based research, innovative therapeutic strategies, and advances in infectious disease management.

The Journal of Infectious Diseases and Therapy aims to advance scientific knowledge by publishing innovative, high-quality research that improves the understanding of infectious diseases, host–pathogen interactions, disease epidemiology, diagnostic methods, therapeutic interventions, antimicrobial stewardship, and preventive strategies. The journal encourages interdisciplinary and translational research that bridges laboratory discoveries with clinical practice and public health to address emerging and persistent infectious disease challenges worldwide.

The Journal of Infectious Diseases and Therapy publishes original research and scholarly articles across all major areas of infectious diseases and related biomedical sciences. The journal welcomes interdisciplinary studies that contribute to the prevention, diagnosis, treatment, surveillance, and control of infectious diseases. Areas of interest include, but are not limited to:

Infectious Diseases
Emerging and Re-emerging Infectious Diseases
Clinical Infectious Diseases
Medical Microbiology
Virology
Bacteriology
Mycology
Parasitology
Tropical and Neglected Tropical Diseases
Zoonotic Diseases
Vector-Borne Diseases
Hospital-Acquired and Healthcare-Associated Infections
Antimicrobial Resistance
Antimicrobial Stewardship
Antiviral, Antibacterial, Antifungal, and Antiparasitic Therapies
Vaccine Development and Immunization
Immunology and Host–Pathogen Interactions
Molecular Diagnostics
Infectious Disease Epidemiology
Public Health and Disease Surveillance
Infection Prevention and Control
One Health
Global Health
Pediatric Infectious Diseases
HIV/AIDS and Sexually Transmitted Infections
Tuberculosis
Viral Hepatitis
Respiratory Infectious Diseases
Foodborne and Waterborne Diseases
Travel Medicine
Sepsis and Critical Care Infections
Clinical Trials in Infectious Diseases
Translational Infectious Disease Research
Precision Medicine in Infectious Diseases
Bioinformatics and Genomic Epidemiology
Artificial Intelligence and Digital Health in Infectious Disease Research

The journal also encourages submissions that integrate microbiology, immunology, molecular biology, genomics, biotechnology, computational biology, pharmacology, and public health to address contemporary challenges in infectious disease prevention and therapy. Manuscripts should demonstrate scientific rigor, ethical integrity, methodological excellence, and the potential to advance clinical practice, healthcare policy, and global infectious disease control.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Platform Statistics

9+
Active Journals
143+
OA Articles

Article Statistics

40.89% 28.41% 30.09%
Accepted Article 28.41%
Rejected Article 40.89%
Submitted Article 30.09%

Current Issue Highlights

AUTHORS: Antonio R. L. Teixeira
Experimental Multidrug Treatment of Chagas Disease
AUTHORS: Wuzhi Zhong, Tao Yan, Lehui Li, Xinguang Zhang, Ru Zhang, Dijia Li, Lijie Ma, Jinli Yan, Chunfa Zhang, Ya Wang, Xiaodong Cao1, Nan Zhang1, and Ziying Zhang
Efficacy and Safety of AKT Inhibitors in HR+/HER2- Breast Cancer or Metastatic TNBC: A Systematic Review and Meta- Analysis of Randomized Clinical Trials

Associated and indexed with

Partner Partner Partner Partner Partner